Vaginal progesterone as luteal phase support in an IVF/GIFT programme.
To determine whether luteal phase support with vaginal progesterone could improve pregnancy rates in our IVF/GIFT programme, we performed a prospective randomised controlled study. After stimulation with clomiphene citrate/human menopausal gonadotrophin, 123 women received no luteal support and 122 received progesterone pessaries 100 mg b.d. from 48 hours prior to embryo transfer and continued throughout the luteal phase. There was no difference in the pregnancy rate following IVF/ET (6/58 and 10/58 for the pessary and control group respectively), but a significantly higher rate was noted for GIFT (13/34 and 5/42 for the pessary and control group respectively; P less than 0.05). Of interest, only one of the 19 pregnancies using luteal support was extra-uterine, compared with 6/15 in the control group.
Polson
D W
DW
Monash IVF Programme, Infertility Medical Centre, Richmond, Victoria, Australia.
Rogers
P A
PA
Krapez
J A
JA
Leeton
J F
JF
D000282:Administration, Intravaginal; D000328:Adult; D002996:Clomiphene / Q000627:therapeutic use; D004624:Embryo Transfer / Q000379:methods; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D015181:Gamete Intrafallopian Transfer / Q000379:methods*; D006801:Humans; D008183:Luteal Phase / Q000187:drug effects*; D008596:Menotropins / Q000627:therapeutic use; D010570:Pessaries; D011247:Pregnancy; D011256:Pregnancy Outcome; D011271:Pregnancy, Ectopic / Q000517:prevention & control; D011374:Progesterone / Q000627:therapeutic use*; D011446:Prospective Studies
D002996:Clomiphene; D011374:Progesterone; D008596:Menotropins